We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canadian Regulation, Safety Measures Stifling Clinical Research, Experts Say
Canadian Regulation, Safety Measures Stifling Clinical Research, Experts Say
August 16, 2010
The “one size fits all” approach to monitoring patient safety in clinical trials has led to a decline in the number of new research studies in developed countries and threatens access to new treatments, an editorial in the July Canadian Medical Association Journal (CMAJ) says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor